News | May 05, 2023
Nouscom reaches clinical phase II using ProBioGen’s AGE1.CR.pIX production platform
Nous-209 has been developed using the Nouscom's viral vector platform
Nous-209 has been developed using the Nouscom's viral vector platform
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
UAB Medexy's first order under the Distribution Agreement is for over 5000 units of SHIR and RELIEF&GO products
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
Subscribe To Our Newsletter & Stay Updated
